Insider Selling: Targeted Medical Pharma CEO Sells 2,000 Shares of Stock (TRGM)
Targeted Medical Pharma (NASDAQ:TRGM) CEO William Shell unloaded 2,000 shares of Targeted Medical Pharma stock on the open market in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $0.60, for a total transaction of $1,200.00. The sale was disclosed in a legal filing with the SEC, which is available at this link.
Targeted Medical Pharma (NASDAQ:TRGM) opened at 0.70 on Friday. Targeted Medical Pharma has a one year low of $0.49 and a one year high of $1.98. The stock’s 50-day moving average is $0.72 and its 200-day moving average is $0.79. The company’s market cap is $18.5 million.
Targeted Medical Pharma Inc is a pharmaceutical company. The Company develops and commercializes nutrient- and pharmaceutical-based therapeutic systems.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.